---
title: 'Associate Director, HCP Promotional Marketing at Summit Therapeutics'
canonical: 'https://feeny.ai/job/associate-director-hcp-promotional-marketing-summit-therapeutics-princeton-jx7vmryd049z'
type: 'job'
last_seen: '2026-11-06'
---

# Associate Director, HCP Promotional Marketing at Summit Therapeutics

- **Company:** Summit Therapeutics
- **Location:** Princeton, NJ
- **Compensation:** $174k–$205k
- **Posted:** 2026-08-13
- **Last confirmed live:** 2026-11-06
- **Apply:** https://job-boards.greenhouse.io/summittherapeutics/jobs/4368623009

## Job description

About Summit:

Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.

Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:

Non-small Cell Lung Cancer (NSCLC)

- HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.

- HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.

- HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.

Colorectal Cancer (CRC)

- HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.

Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.

Overview of Role:

The Associate Director of HCP Promotional Marketing will serve as the Marketing Scientific Strategy Lead across thoracic indications, translating the thoracic HCP strategy and scientific narrative into a robust, integrated plan for marketing scientific strategy & promotional medical education. This role will lead the strategic planning and execution of commercial congresses, product theaters, KOL engagement, advisory boards, speaker programs, and other peer-to-peer promotional tactics.

Reporting to the Director of HCP Promotional Marketing, this individual will partner closely with Medical Affairs to maintain a strong understanding of the clinical data, evidence-generation plans, and anticipated data milestones, while serving as the commercial marketing voice in cross-functional scientific discussions. The role will use this understanding to develop coordinated engagement plans, build trusted relationships with external experts, lead relevant agency partners, and ensure the HCP strategy and scientific narrative are activated through cohesive, differentiated, and compliant peer-to-peer experiences across thoracic indications.

Role and Responsibilities:

- Serve as the Marketing Scientific Strategy Lead across thoracic indications, translating the HCP strategy, scientific narrative, clinical data, and evolving evidence base into integrated promotional medical education, congress, product theater, KOL engagement, and peer-to-peer tactical plans.
- Lead promotional medical education strategy and execution, including content development, channel and execution strategy, agency leadership, speaker training, and content readiness, while supporting ongoing speaker bureau management in partnership with Commercial Operations.
- Own regional & national commercial congress strategy and execution (in partnership with commercial operations) across thoracic indications, including promotional presence, product theaters, scientific engagement opportunities, and coordination of cross-functional and agency partners.
- Lead product theater strategy, planning & content development while partnering with regional marketing on the execution and faculty management.
- Develop and maintain strategic relationships with key opinion leaders and other external experts to inform commercial scientific strategy, identify emerging insights, and support meaningful HCP engagement.
- Lead commercial advisory board strategy, planning, content development, faculty selection and engagement, execution, and synthesis of actionable insights in close partnership with relevant cross-functional stakeholders.
- Lead development and execution of peer-to-peer tactics and promotional initiatives, ensuring scientific accuracy, strategic consistency, operational excellence, and compliant execution across channels.
- Partner closely with Medical Affairs to understand current and emerging data, evidence-generation plans, publication and congress milestones, and anticipated data readouts; represent the commercial perspective and identify implications for HCP strategy and promotional planning.
- Translate complex scientific and clinical information into clear, compelling, and compliant promotional education, speaker content, and HCP engagement experiences.
- Collaborate cross-functionally with Medical, Legal, Regulatory, Market Access, and Insights to ensure high-quality, compliant execution
- Travel as needed to support congresses, advisory boards, speaker training, KOL engagements, and other key business priorities.
- All other duties as assigned

Experience, Education and Specialized Knowledge and Skills:

- Bachelor's degree in Business, Marketing, or a related field; MBA or advanced degree preferred
- Minimum of 8+ years of pharmaceutical or biotech commercial experience, including HCP marketing experience in oncology
- Demonstrated experience supporting commercial launch activities and/or pre-launch activities
- Demonstrated experience leading or supporting promotional medical education, peer-to-peer programs, speaker bureaus, advisory boards, congress planning, and KOL engagement
- Strong scientific acumen with demonstrated ability to interpret and translate complex oncology data into impactful, compliant HCP materials and field communications
- Proven project management skills with ability to manage multiple workstreams in a fast-paced, launch-focused environment
- Excellent communication skills with the ability to influence and lead through collaboration without direct authority
- Strong cross-functional experience with Marketing, Insights, Market Access, Medical, Legal, and Compliance
- Track record of operating with high integrity and maintaining compliance with regulatory, legal, and operational standards
- Ability to thrive in evolving, dynamic, and fast-paced pre-launch or launch-phase environments with shifting data and priorities
- Ability to travel as business needs require

This is the pay for this position

Pay Transparency $174,000—$204,500 USD

Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.

Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit.

Summit Therapeutics Inc. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.

## About Summit Therapeutics

## Company Overview
- **One-liner**: Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on discovering, developing, and commercializing novel bispecific antibody therapies, with its lead candidate ivonescimab targeting PD-1 and VEGF for multiple solid tumors.
- **Entity Type**: Public (NASDAQ: SMMT)
- **Headquarters**: Miami, Florida, USA (with additional offices in Palo Alto, CA; Princeton, NJ; Oxford, UK; and Dublin, Ireland)
- **Founded**: 2003
- **Founders**: Not publicly disclosed on the company website; the company was founded in 2003.

## Core Business
- **Primary industry**: Biopharmaceuticals / Oncology
- **Target customers**: B2B (healthcare providers, patients, and caregivers) with a focus on resolving serious unmet medical needs in oncology
- **Mission statement**: "To resolve serious, unmet medical needs for the betterment of overall human health." [smmttx.com](https://smmttx.com/company/about-us/default.aspx)

## Products & Services
- **Ivonescimab (SMT112)**: A novel, potential first-in-class investigational bispecific antibody targeting both PD-1 and VEGF. It is designed to combine immunotherapy (PD-1 blockade) with anti-angiogenesis (VEGF blockade) into a single molecule. Currently being studied in several global Phase 3 clinical trials for non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and head and neck squamous cell carcinoma (HNSCC). Licensed from Akeso, Inc. (HKEX: 9926.HK) for territories including the U.S., Canada, Europe, Japan, Latin America, the Middle East, and Africa. [smmttx.com](https://smmttx.com/pipeline/default.aspx)

## Market Standing
- **Valuation/Market Cap**: Approximately $2.7 billion (as of recent data) [linkedin.com](https://www.linkedin.com/company/summit-therapeutics)
- **Key Metric**: Annual revenue of approximately $705,000 (reported). The company is pre-commercialization and heavily investing in R&D. Total funding raised since IPO (2015) is not disclosed, but the company has a strong cash position from equity offerings.
- **Notable Investors/Partners**: Akeso, Inc. (key licensing partner for ivonescimab). The company is publicly traded with institutional and retail investors.
- **Growth Signals**: 
  - Headcount grew 72.5% year-over-year to 244 employees. [linkedin.com](https://www.linkedin.com/company/summit-therapeutics)
  - Multiple global Phase 3 trials actively recruiting (HARMONi, HARMONi-3, HARMONi-7, HARMONi-GI3, ILLUMINE).
  - Over 4,000 patients have been treated with ivonescimab across all clinical trials globally. [smmttx.com](https://smmttx.com/pipeline/default.aspx)
  - Achieved Great Place to Work® Certification. [smmttx.com](https://smmttx.com/careers/careers-overview/default.aspx)

## Competitive Advantages
- **Novel Mechanism**: Ivonescimab is a first-in-class bispecific antibody targeting both PD-1 and VEGF simultaneously, potentially offering superior efficacy and fewer side effects compared to combination therapies.
- **Speed and Execution**: The company emphasizes "high-speed execution in commercialization" and has rapidly initiated multiple Phase 3 trials.
- **Global Reach**: Licensed territories cover major markets (U.S., Canada, Europe, Japan, Latin America, Middle East, Africa) with a strong partner (Akeso) in the rest of the world.
- **Strong Balance Sheet**: With a $2.7B market cap and public listing, the company has access to capital markets to fund its pipeline.

## Strategic Focus
- **Current priorities**: Advancing ivonescimab through Phase 3 clinical trials across multiple solid tumor indications (NSCLC, CRC, HNSCC), with the goal of regulatory approval and commercialization.
- **Future direction**: Expanding the pipeline into additional solid tumors and leveraging the bispecific platform for future therapies. The company is focused on becoming a leading oncology player.
- **Near-term milestones**: Data readouts from ongoing Phase 3 trials, potential regulatory submissions, and building commercial infrastructure.

## Why Work Here
- **Culture**: The company has achieved Great Place to Work® Certification, indicating a positive, supportive, and fulfilling work environment. Core values include Commitment to People, Integrity, Passion for Excellence, Purposeful Urgency, Accountability, and Collaboration. [smmttx.com](https://smmttx.com/careers/careers-overview/default.aspx)
- **Work Environment**: Fast-paced, high-energy atmosphere focused on innovation and collaboration. The company emphasizes "making a significant difference in patients’ lives."
- **Benefits (U.S.)**: 
  - 401(k) with 6% employer match
  - Employee Stock Purchase Plan (ESPP) with 15% discount up to the annual federal limit
  - Flexible Spending Account
  - Commuter Benefit
  - Onsite lunch provided
- **Benefits (U.K.)**: 
  - Private Medical Insurance
  - Employee Assistance Program
  - Life Assurance Policy
  - Company Pension Contributions
  - ESPP
- **Remote/Hybrid Policy**: Not explicitly stated, but multiple office locations suggest a hybrid or on-site presence is expected for many roles.
- **Open Roles**: 25 active job postings (as of recent data) including Senior Director of Sales Operations, Clinical Scientists, Medical Science Liaisons, and Drug Product MSAT roles. [greenhouse.io](https://job-boards.greenhouse.io/summitherrapeutics)
- **Headcount Growth**: 72.5% year-over-year growth signals a scaling organization with opportunities for career advancement.

## Sources
1. [smmttx.com - About Us](https://smmttx.com/company/about-us/default.aspx)
2. [smmttx.com - Investor Relations Overview](https://www.smmttx.com/overview/default.aspx)
3. [smmttx.com - Pipeline](https://smmttx.com/pipeline/default.aspx)
4. [smmttx.com - Careers Overview](https://smmttx.com/careers/careers-overview/default.aspx)
5. [linkedin.com - Summit Therapeutics Company Page](https://www.linkedin.com/company/summit-therapeutics)
6. [greenhouse.io - Summit Therapeutics Careers](https://job-boards.greenhouse.io/summitherrapeutics)

## Other roles at Summit Therapeutics

- [Executive Oncology Account Manager (Asheville)](https://feeny.ai/job/executive-oncology-account-manager-asheville-summit-therapeutics-asheville-xea3xrskjcqw) — Asheville, NC
- [Executive Oncology Account Manager (Portland)](https://feeny.ai/job/executive-oncology-account-manager-portland-summit-therapeutics-portland-0cjhm9gw84jh) — Portland, OR
- [Executive Oncology Account Manager (Memphis)](https://feeny.ai/job/executive-oncology-account-manager-memphis-summit-therapeutics-memphis-n4vbnmrsdwqb) — Memphis, TN
- [Executive Oncology Account Manager (Des Moines)](https://feeny.ai/job/executive-oncology-account-manager-des-moines-summit-therapeutics-des-moines-a8wf1x3paf3y) — Des Moines, IA
- [Executive Oncology Account Manager (Knoxville)](https://feeny.ai/job/executive-oncology-account-manager-knoxville-summit-therapeutics-knoxville-g3gr9z1f730s) — Knoxville, TN
- [Associate Director, CMC / Quality Project Management](https://feeny.ai/job/associate-director-cmc-quality-project-management-summit-therapeutics-princeton-0bc35yd129z5) — Princeton, NJ
- [Senior Clinical Trial Manager](https://feeny.ai/job/senior-clinical-trial-manager-summit-therapeutics-remote-6zvca64c4wcr)
- [Executive Oncology Account Manager (Fort Worth)](https://feeny.ai/job/executive-oncology-account-manager-fort-worth-summit-therapeutics-fort-worth-q76xdp78qxqz) — Fort Worth, TX
- [Executive Oncology Account Manager (Cincinnati)](https://feeny.ai/job/executive-oncology-account-manager-cincinnati-summit-therapeutics-cincinnati-yr41k1s11h9s) — Cincinnati, OH
- [Executive Oncology Account Manager (Worcester)](https://feeny.ai/job/executive-oncology-account-manager-worcester-summit-therapeutics-worcester-ggnt93btghw6) — Worcester, MA